Solas Fiduciary Services (Solas), a privately owned leader in directorships & corporate governance, continues to strengthen its presence in the Dubai International Financial Centre (DIFC) with the appointment of Craig Roberts to its team of independent directors. https://mma.prnewswire.com/media/2835277/DSC_4483_copy1.jpg Craig has over 30 years' experience in the financial services industry globally, having held senior positions in […]
TRUBAR: the plant-based protein bars VANCOUVER, British Columbia, Dec. 02, 2025 (GLOBE NEWSWIRE) — According to CPG Insider, TRUBAR, a better-for-you bar brand under Simply Better Brands (TSE: TRBR), was announced last week to be acquired by ETÄ° Gıda in a $201 million (CAD) all-cash transaction. The deal, representing a 64% premium over TRUBAR's previous
$201M (CAD) Exit for Bar Brand TRUBAR Reported Last Week by CPG Insider – Founded by Former NFL Player Brad Pyatt and His Wife Acquisition highlights ETÄ° Gıda's global expansion strategy and positions TRUBAR for accelerated growth in the better-for-you snacks category. GlobeNewswire December 03, 2025 TRUBAR: the plant-based protein bars VANCOUVER, British Columbia, Dec.
540 members impacted by acyberattack that targeteda contracted vendor of the health plan Gold Coast Health Plan (GCHP) recently discovered that one of its contracted business partners suffered a cyberattack that resulted in the potential disclosure of member information to an unauthorized third party. https://mma.prnewswire.com/media/2633459/Gold_Coast_Health_Plan_Logo.jpg Conduent Business Solutions, a longtime administrative services vendor for GCHP,
Dallas, Texas–(Newsfile Corp. – December 2, 2025) – G4 Dental Implants Dallas, a nationally recognized leader in full-arch dental implant solutions, proudly announces its expanded Veterans Program—a special initiative led by Dr. Andrew Kelsey, dedicated to providing U.S. veterans with access to advanced, life-changing dental implant care. Serving Those Who Served Many veterans face significant
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses in aTyr to Contact Him Directly to Discuss Their Options If you purchased or acquired securities in aTyr between January 16, 2025 and September 12, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh
— FDA approval of OMLYCLO® (omalizumab-igec) 300 mg/2 mL solution in a single-dose prefilled syringe for subcutaneous injection expands dosing flexibility and supports tailored treatment for individual patients with certain allergic diseases — OMLYCLO® (omalizumab-igec) is the first and only biosimilar designated as interchangeable with XOLAIR® (omalizumab); The FDA previously approved OMLYCLO® 75 mg/0.5 mL
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses in Telix to Contact Him Directly to Discuss Their Options If you purchased or acquired securities in Telix between February 21, 2025 and August 28, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh
Product:Pistachios and pistachio-containing products Issue: Food – Microbial contamination – Salmonella Distribution:OnlineAlbertaBritish ColumbiaManitobaNew BrunswickNewfoundland and LabradorOntarioQuebecSaskatchewan Online link Media and public enquiriesPublic enquiriesToll-free: 1-800-442-2342 (Canada and U.S.)Telephone: 1-613-773-2342 (local or international)Email:information@inspection.gc.ca SOURCE Canadian Food Inspection Agency (CFIA) https://rt.newswire.ca/rt.gif?NewsItemId=C9964&Transmission_Id=202512021935CANADANWWEB______C9964&DateId=20251202
Vancouver, British Columbia–(Newsfile Corp. – December 2, 2025) – Gunpoint Exploration Ltd. (TSXV: GUN) (“Gunpoint” or the “Company”) is pleased to announce that it has closed its previously announced non-brokered private placement financing for gross proceeds of $3,350,000 from the sale of 8,375,000 units (the “Units”) at a price of $0.40 per Unit (the “Offering”).